GREY:IMVIF - Post by User
Comment by
alphaseeking001on Dec 12, 2020 4:28pm
349 Views
Post# 32094027
RE:RE:RE:RE:RE:Technical assistance
RE:RE:RE:RE:RE:Technical assistance Agreed Rocklobster on the chart. I do think that for once it doesn't really reflect IMVs value right now. I agree with QM45 that the cancer program is truly advancing well on multiple fronts now... just not reflected in the SP... yet. Agreed that tax loss selling may push us below the support of $4 in the last two weeks here. I've been buying a bit lately again as I said. For once I feel like I'm not overpaying. If it does drop below 4 I will buy more in the mid 3s similar to you. I see quite a few catalysts in 2021 and for once I am not fearing another sudden financing! I haven't been in IMV as long as you but it's been at least 7-8 y. Got out in the summer diuring that crazy day and have been buying here and there since beginning in the low 5s. I've finally accepted that I need to look at IMV with a medium to longer term lens. I think we are within 1-2y of significant positive changes. Hopefully we start a SP uptrend in 2021
RockLobster1 wrote:
I think the chart looks horrible at the moment with ugly reversals on Nov 12 and Dec 1... and with the potential tax loss selling of the people who bought based on a 'covid vaccine' headline we could break 4 cad and head to 3.20-3.60.
I sold half earlier this year and bought back some at 4.40 recently on the news... not that i understand biotech well but seemed good news :)
So I will put in orders under here around 3.20-3.60 and see if we break below $4 this month. If it doesnt break then hopefully i can add close to 4...
But if i didnt already have a big position (for me) I'd be more aggressive. I have been trading in and out since 2010 IPO... wow. Can be a very frustrating stock but overall it's been profitable so cant complain...